Send to

Choose Destination
See comment in PubMed Commons below
Int J Biochem Mol Biol. 2012;3(3):273-81. Epub 2012 Sep 25.

Induction of cell senescence by targeting to Cullin-RING Ligases (CRLs) for effective cancer therapy.

Author information

Department of Immunology, Shanghai Medical College, Fudan University Shanghai 200032, China.


Cullin-RING ligases (CRLs) are the biggest family of multiunit ubiquitin E3 ligases, controlling many biological processes by promoting the degradation of a broad spectrum of proteins associated with cell cycle, signal transduction and cell growth. The dysfunction of CRLs causes a lot of diseases including cancer, which meanwhile offers us a promising approach to cancer therapy by targeting to CRLs. Recent studies have demonstrated that genetic or pharmaceutical inactivation of CRLs often leads to cancer cell death by activating multiple cell-killing pathways including senescence, an emerging anticancer mechanism of therapeutic agents. Here, we summarize the induction of cellular senescence and its mechanism of action, triggered by targeting to specific subunits of CRLs via multiple approaches including siRNA silencing, genetic knockout as well as small molecule inhibitor, exhibiting anticancer effect in vitro and in vivo.


CRLs; MLN4924; RBX1/ROC1; Skp2; cullin neddylation; senescence

PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Support Center